Inventor · disambiguated record
Gabrielle R. Kolakowski
Also filed as: KOLAKOWSKI GABRIELLE R
58 granted patents·14 pending applications·448 citations·filing 2011–2024
98Inventor score
Top patents by PatentIndex Score
72 records- 0198US10174028B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·14 cites·29 claims
- 0298US10174027B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jan 8, 2019·17 cites·30 claims
- 0398US10138243B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·14 cites·29 claims
- 0498US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0598US9493476B2Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Nov 15, 2016·46 cites·14 claims
- 0697US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 0797US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 0897US10023570B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jul 17, 2018·14 cites·103 claims
- 0997US9902741B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 27, 2018·22 cites·15 claims
- 1097US9840519B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·21 cites·5 claims
- 1197US9750744B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Sep 5, 2017·21 cites·29 claims
- 1297US9718822B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Aug 1, 2017·22 cites·15 claims
- 1396US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 1495US8933084B2Macrocyclic compounds as Trk kinase inhibitorsANDREWS STEVEN WADE·Filed 2011·Granted Jan 13, 2015·113 cites·52 claims
- 1594US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 1693US10647730B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted May 12, 2020·4 cites·15 claims
- 1792US10584124B2Crystalline formsARRAY BIOPHARMA INC·Filed 2018·Granted Mar 10, 2020·12 cites·9 claims
- 1891US10907215B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2018·Granted Feb 2, 2021·3 cites·27 claims
- 1991US10688100B2Macrocylic compounds as ROS1 kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jun 23, 2020·3 cites·3 claims
- 2091US10172845B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·4 cites·29 claims
- 2190US11873295B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Granted Jan 16, 2024·3 cites·125 claims
- 2290US10724102B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2016·Granted Jul 28, 2020·3 cites·44 claims
- 2390US10655186B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2017·Granted May 19, 2020·3 cites·14 claims
- 2489US10144734B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 4, 2018·6 cites·30 claims
- 2588US10441581B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Oct 15, 2019·2 cites·29 claims
- 2687US11998545B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Granted Jun 4, 2024·0 cites·14 claims
- 2787US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 2887US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 2985US10378068B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2017·Granted Aug 13, 2019·3 cites·20 claims
- 3085US10370727B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2017·Granted Aug 6, 2019·3 cites·20 claims
- 3184US11697647B2RET kinase inhibitorsLILLY CO ELI·Filed 2021·Granted Jul 11, 2023·1 cites·25 claims
- 3284US10745419B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2018·Granted Aug 18, 2020·2 cites·19 claims
- 3384US9896435B2N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Feb 20, 2018·3 cites·29 claims
- 3482US10881652B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 5, 2021·2 cites·14 claims
- 3582US10323022B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 18, 2019·2 cites·26 claims
- 3681US11649227B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2021·Granted May 16, 2023·1 cites·20 claims
- 3781US11098064B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrileLOXO ONCOLOGY INC·Filed 2020·Granted Aug 24, 2021·1 cites·9 claims
- 3880US9133187B2Serine/threonine kinase inhibitorsBLAKE JAMES F·Filed 2012·Granted Sep 15, 2015·6 cites·20 claims
- 3980US2023090520A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4076US2021186959A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4175US2019127373A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4275US2021164055A1Point mutations in trk inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 4375US2019127374A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4475US2019127375A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4573US11964968B2Compounds useful for inhibiting RET kinaseLILLY CO ELI·Filed 2023·Granted Apr 23, 2024·0 cites·23 claims
- 4673US2020291026A1Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4772US11648243B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted May 16, 2023·0 cites·20 claims
- 4870US10351575B2Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of painARRAY BIOPHARMA INC·Filed 2013·Granted Jul 16, 2019·1 cites·48 claims
- 4969US11851434B2Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Granted Dec 26, 2023·0 cites·16 claims
- 5069US11807651B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2021·Granted Nov 7, 2023·0 cites·11 claims
Showing the top 50 of 72 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →